|
Volumn 121, Issue 3 SUPPL., 2002, Pages 679-681
|
Prevention of ventilator-associated pneumonia: Selecting interventions that make a difference
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
FIBRONECTIN;
FIBRONECTIN ANTIBODY;
SUCRALFATE;
UNCLASSIFIED DRUG;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
ARTIFICIAL VENTILATION;
ASPIRATION;
BACTERIAL COLONIZATION;
BACTERIUM ADHERENCE;
BIOFILM;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
EDITORIAL;
ENDOTRACHEAL TUBE;
HOSPITAL INFECTION;
HUMAN;
INFECTION CONTROL;
INTENSIVE CARE UNIT;
INTERMETHOD COMPARISON;
LENGTH OF STAY;
MORTALITY;
PATHOGENESIS;
PATIENT POSITIONING;
PNEUMONIA;
POSITIVE END EXPIRATORY PRESSURE;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
RANDOMIZED CONTROLLED TRIAL;
STAPHYLOCOCCUS AUREUS;
STRESS ULCER;
TREATMENT OUTCOME;
|
EID: 0036202797
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.121.3.679 Document Type: Editorial |
Times cited : (20)
|
References (24)
|